Highly sensitive diagnostic tests for the prevention of sudden cardiac death Robert Hamilton, MD Staff Cardiologist Senior Scientist | Translational Medicine Technology 1-Pager Full Bio Sudden Cardiac Death (SCD) causes more years of potential life lost than any other non-cancer [...]
Engineered human alveolar-like macrophages as a cell therapy for respiratory diseases Martin Post, PhD Senior Scientist | Translational Medicine Technology 1-Pager Lab Website Currently, there are inadequate therapeutic options for major respiratory diseases caused by prolonged inflammation leading to tissue [...]
Methods of treating trinucleotide repeat expansion diseases Christopher Pearson, PhD Senior Scientist | Genetics & Genome Biology Technology 1-Pager Full Bio Dr. Christopher Pearson is a Senior Scientist at SickKids with over 25 years of research in molecular genetics. The [...]
A novel cell-penetrant delivery platform applied to a pan-Ras targeting anti-cancer therapy Roman Melnyk, PhD Senior Scientist | Molecular Medicine Technology 1-Pager Lab Website Dr. Roman Melnyk has brought his industry experience from Merck & Co. to his role as [...]
Novel therapeutic compositions for degrading bacterial and fungal biofilms P. Lynne Howell, PhD Senior Scientist | Molecular Medicine Technology 1-Pager Lab Website Bacteria and fungal colonies produce a protective coating barrier called a biofilm, which makes it difficult for traditional [...]
SickKids Ranked One of Canada's Top 40 Research Hospitals for 2021 SickKids has once again been named one of Canada’s top research hospitals by Research Infosource. SickKids ranks first in both researcher intensity and hospital intensity among medium-sized hospitals on the list. For the eleventh consecutive [...]
Pfizer Completes Acquisition of Trillium Therapeutics On November 17, 2021, Pfizer Inc. announced the successful completion of its acquisition of Trillium Therapeutics, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. This is a great development for Trillium’s foundational technology, based on [...]
SickKids scientist Dr. Jean-Philippe Julien named one of Canada's Top 40 Under 40 Congratulations to Dr. Jean-Philippe Julien, one of our entrepreneurial scientists at The Hospital for Sick Children, on being named a 2021 Honouree of Canada’s Top 40 Under 40! Read the full story on SickKids. [...]
SickKids and U of T spinout PhenoTips raises $2.5 million in seed funding Genetics software start-up PhenoTips, a spinout from The Hospital for Sick Children (SickKids) and University of Toronto (U of T), announced this week that it has raised $2.5 million in a seed funding [...]
General Inquiries
Email: ipc.requests@sickkids.ca
Peter Gilgan Centre for Research and Learning
686 Bay Street, Toronto
Ontario, Canada
M5G 0A4
SickKids Industry Partnerships & Commercialization operates on the traditional land of the Huron-Wendat and Petun First Nations, the Seneca, and the Mississaugas of the Credit River.
© 1999 – 2024 The Hospital for Sick Children (SickKids) – All Rights Reserved.
